Pediatric Augmentin Dosing for Outpatient Paronychia
For pediatric patients ≥3 months with paronychia requiring outpatient antibiotic therapy, prescribe amoxicillin-clavulanate (Augmentin) at 45 mg/kg/day divided twice daily (based on the amoxicillin component), administered for 7-10 days with meals. 1
Dosing Rationale and Formulation Selection
The standard-dose formulation (not the high-dose ES-600) is appropriate for paronychia, as this is a soft tissue infection without the same resistance concerns seen in recurrent otitis media. The twice-daily regimen improves compliance and reduces gastrointestinal side effects compared to three-times-daily dosing 2.
Specific Weight-Based Dosing
For the standard formulation providing approximately 45 mg/kg/day:
- Use the 400 mg/5 mL suspension
- Dose: approximately 22.5 mg/kg per dose, twice daily
- Example: A 20 kg child would receive approximately 10 mL (400 mg) twice daily
Critical formulation warning: Do not substitute different Augmentin suspensions interchangeably - they contain different amounts of clavulanic acid. The 200 mg/5 mL, 400 mg/5 mL, and ES-600 formulations are NOT equivalent 1.
Clinical Context for Paronychia
Paronychia is classified as a skin and soft tissue infection requiring coverage of both aerobic and anaerobic bacteria. The 2014 IDSA guidelines specifically recommend amoxicillin-clavulanate for bite wounds and infections requiring mixed aerobic-anaerobic coverage 3. While paronychia isn't explicitly mentioned, it falls within this category of polymicrobial soft tissue infections.
Recent microbiological data shows Staphylococcus aureus is the predominant pathogen (approximately 30% of cases), with amoxicillin-clavulanate demonstrating only 4.7% resistance rates 4. This supports its use as empiric first-line therapy.
Administration Guidelines
- Timing: Administer at the start of meals to minimize gastrointestinal intolerance and enhance clavulanate absorption 1
- Duration: 7-10 days is standard for uncomplicated paronychia
- Storage: Reconstituted suspension remains stable for 10 days under refrigeration 1
- Preparation: Shake well before each use
Key Caveats and Pitfalls
Age restriction: This dosing applies only to children ≥3 months old. Neonates and infants <3 months require different considerations 1.
Hepatic impairment: Dose with caution and monitor hepatic function in patients with liver disease 1.
When NOT to use antibiotics: For simple, uncomplicated paronychia that can be adequately drained, postoperative antibiotics may not influence recurrence rates and should be avoided to support antimicrobial stewardship 4.
Resistance considerations: If the patient has risk factors for MRSA (recent hospitalization, recurrent skin infections, prior MRSA), amoxicillin-clavulanate will not provide adequate coverage and alternative agents should be considered 3.
Practical Prescribing
The twice-daily regimen shows equivalent efficacy to three-times-daily dosing with trends toward better compliance (82.8% vs 73.3%) and lower diarrhea rates (7.2% vs 10.7%) 2. This makes it the preferred outpatient regimen for pediatric patients.
For patients requiring higher doses due to treatment failure or resistant organisms, the ES-600 formulation provides 90 mg/kg/day divided twice daily, but this is typically reserved for recurrent/persistent infections rather than initial paronychia treatment 1, 5.